GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » Debt-to-Asset

Lombard Medical Technologies (LSE:LMT) Debt-to-Asset : 0.30 (As of Dec. 2012)


View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies Debt-to-Asset?

Lombard Medical Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2012 was £2.76 Mil. Lombard Medical Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2012 was £0.00 Mil. Lombard Medical Technologies's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2012 was £9.24 Mil. Lombard Medical Technologies's debt to asset for the quarter that ended in Dec. 2012 was 0.30.


Lombard Medical Technologies Debt-to-Asset Historical Data

The historical data trend for Lombard Medical Technologies's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies Debt-to-Asset Chart

Lombard Medical Technologies Annual Data
Trend Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 - - - 0.30

Lombard Medical Technologies Semi-Annual Data
Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 - - - 0.30

Competitive Comparison of Lombard Medical Technologies's Debt-to-Asset

For the Medical Instruments & Supplies subindustry, Lombard Medical Technologies's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lombard Medical Technologies's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lombard Medical Technologies's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Lombard Medical Technologies's Debt-to-Asset falls into.



Lombard Medical Technologies Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Lombard Medical Technologies's Debt-to-Asset for the fiscal year that ended in Dec. 2012 is calculated as

Lombard Medical Technologies's Debt-to-Asset for the quarter that ended in Dec. 2012 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lombard Medical Technologies  (LSE:LMT) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Lombard Medical Technologies Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Lombard Medical Technologies (LSE:LMT) Business Description

Traded in Other Exchanges
N/A
Address
Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.